Hexima is now recruiting patients for its fungal nail infection clinical trial. Interested in volunteering? Find out more at www.toenailstudy.com.au.
- Hexima doses first patient in phase 1/2a trial of HXP124 as a novel topical treatment for fungal nail infections
- Recruiting patients for fungal nail study
- VIDEO: CSO Marilyn Anderson interviewed by the AAS.
- Hexima AGM 2017 – Presentations and Results
- Hexima receives approval to conduct a phase 1/2a study for fungal nail infections